291 Campus Drive
Stanford, CA 94305
USA
METRICS invites you to a forum on:
Ethics, Trust, and Drug Innovation: Could Ranking New Drugs and Companies on Clinical Trial Transparency and Other Ethics Performance Metrics Help?
Presented by:
Jennifer E. Miller, Ph.D.
Assistant Professor, Department of Population Health, NYU School of Medicine
President, Bioethics International, Creator of the Good Pharma Scorecard
Monday, October 31, 2016
12:00-1:00 pm PST
Frances C. Arrillaga Alumni Center—Fisher Conference Center
Lunch will be served
To attend RSVP online by October 26, 2016
(Please note, RSVP required due to room capacity)
Speaker bio: Jennifer E. Miller, PhD, is an Assistant Professor at NYU School of Medicine, where she serves on the Stem Cell Research Oversight IRB, the J&J-NYU Compassionate-Use Advisory Committee (monitor), and Pharmacy and Therapeutics Committee (non-voting). She is also president of Bioethics International. Prior to joining NYU, she completed postdoctoral fellowships at Harvard University’s Edmond J. Safra Center for Ethics and Duke University’s Kenan Institute for Ethics. Her work explores the ethics and governance of how drugs are researched, developed, marketed, and made accessible to patients globally. She created the Good Pharma Scorecard, an index that ranks new drugs, along with their sponsors, on critical ethics and public health performance criteria to help recognize good practices in companies, improve trustworthiness, and incentivize change where needed.